BIOHK2022: Hong Kong needs a more integrated and harmonised ecosystem to become a biotech fundraising hub, panellists say

December 15, 2022 Chin@Strategy

From left, Bin Li of Lake Bleu Capital, Vijay Karwal of AffaMed Therapeutics, Donald Lung, CFO of Antengene and Yinxiang Wang, chairman and CEO of Jacobio Pharma, take part in a panel discussion on ‘Capital Market for Healthcare Post Pandemic’ at BIOHK2022 on Thursday. Photo: Handout

South China Morning Post

Related posts

• October 18, 2025 Media Library 0

  ‘You’re in spy territory’: how two UK nationals got tangled in a Chinese espionage row

  For Christopher Cash it was а job he adored. The young parliamentary researcher, then in his...

• 

  October 18, 2025 Media Library 0

  Chinese Nobel Prize-winning physicist Chen-ning Yang dies, aged 103

  Nobel Prize-winning theoretical physicist Chen-ning Yang, died in Beijing on Saturday at the age of 103....

• 

  October 18, 2025 Media Library 0

  China-made motor sales surge in South Africa, cutting into rival brands’ dominance

  Advertisement In recent years, South Africans have increasingly been buying Chinese brands like Chery and Haval,...